Invega Sustenna 100mg (Paliperidone palmitate Vials) 100mg

Invega Sustenna 100mg is an injectable antipsychotic medication containing paliperidone palmitate. It is used for schizophrenia and schizoaffective disorder symptom management. This long-acting injectable provides sustained release for consistent medication levels. Store at room temperature away from moisture.

Strength

100mg

Pack Size

Storage

Ambient

Manufacturer / TM Owner

Janssen pharmaceutica NV

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Invega Sustenna 100mg is primarily used to treat schizophrenia and schizoaffective disorder. It helps manage symptoms such as hallucinations, delusions, and disorganized thinking. The medication works by adjusting certain neurotransmitters in the brain to improve mood and behavior. It is designed for long-term maintenance therapy.

Side Effects

Common effects may include mild injection site reactions like pain or swelling. Some users report drowsiness, dizziness, or mild gastrointestinal discomfort. These effects are typically temporary and may lessen as the body adjusts. Regular monitoring helps manage any persistent reactions.

Precautions & Warnings

Keep this medication in its original packaging until ready for use. Store at room temperature, away from heat and moisture. Avoid freezing or exposing to direct sunlight. Keep out of reach of children and pets. Handle vials carefully to prevent breakage or contamination.

Avoid Interactions

Alcohol may increase drowsiness or dizziness when combined with this medication. Certain medications, such as strong CYP3A4 inhibitors or inducers, may affect how paliperidone works. Always inform your healthcare provider about all medications and supplements you are taking. Avoid abrupt changes without professional guidance.

Frequently Asked Questions

Invega Sustenna 100mg is used to treat schizophrenia and schizoaffective disorder.

It is given as an injection by a healthcare professional, typically once a month.

Common side effects may include injection site reactions, drowsiness, or mild gastrointestinal discomfort.

Alcohol may increase drowsiness or dizziness; consult your healthcare provider before consuming.

Store at room temperature, away from heat, moisture, and direct sunlight.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.